Pilot study of absolute ethanol injection sclerotherapy for lymphangioma circumscriptum

Pilot study of absolute ethanol injection sclerotherapy for lymphangioma circumscriptum - Absolute ethanol sclerotherapy for lymphangioma circumscriptum

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011130

Enrollment

Registered

2013-07-08

Start date

2013-07-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphangioma circumscriptum

Interventions

Absolute ethanol injections at a time into the lesion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Any lymphangioma circumscriptum patients requiring treatment who had given us an informed consent to participate in this clinical study

Exclusion criteria

Exclusion criteria: Not hypersensitive to alcohol

Design outcomes

Primary

Measure	Time frame
improvement of the lesion	—

Secondary

Measure	Time frame
improvement of the symptom	—

Countries

Japan

Contacts

Public ContactAkihiro Fujino

National Center for Child Health and Development Department of Pediatric Surgery

fujino-a@ncchd.go.jp03-5494-7144

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026